EVP, Head of Research & Dev · ACADIA PHARMACEUTICALS INC · Common Stock
Side
SELL
Value
$74K
Shares
3,435
Price
$21.47
Executed
Mar 25, 2026
Disclosed
Mar 26, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Mar 25 executedMar 26, 2026 disclosed
ACAD · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+15 / 15
3 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Thompson Elizabeth H.Z. filed this Form 4 reporting a open-market sale of ACAD on Mar 25, 2026. It became public on Mar 26, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
EVP, Head of Research & Dev
Thompson Elizabeth H.Z.cik:0001861477
Issuer
ACADIA PHARMACEUTICALS INCcik:0001070494
Revision history · 0
No field has changed since this record was first ingested.
